Organization · Venture Capital
Solas BioVentures
Solas BioVentures is an early-stage venture capital firm based in Chattanooga, Tennessee, specializing in investments in the life sciences sector, including biopharmaceuticals, medical devices, and digital health technologies.
Overview
What Solas BioVentures does
What Solas BioVentures is
Solas BioVentures is an early-stage venture capital firm based in Chattanooga, Tennessee, specializing in investments in the life sciences sector, including biopharmaceuticals, medical devices, and digital health technologies.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2015
- Approximate age
- About 11 years
- Structured capabilities
- Funder
- Last reviewed
- April 9, 2026
Official channels
Find Solas BioVentures elsewhere
Open the official website or a supported primary organization account.
Capability profile
Solas BioVentures as a funder
Investment thesis
Founder-centric approach to enabling breakthrough medicine and technology innovation. Invests exclusively in life sciences.
Focus narrative
Solas BioVentures invests exclusively in the life science sector, targeting early-stage opportunities in biopharmaceuticals, medical devices, and digital health. The firm aims to enable breakthrough innovations that can significantly impact healthcare.
Value beyond capital
Solas BioVentures adds value through its founder-centric approach, leveraging the team's extensive experience in medical, biotech, and operational fields to guide portfolio companies towards successful commercialization.
Terms and economics
- Typical check
- $500,000–$5,000,000
Focus and fit
- Stages
- Pre-seed · Seed · Seed+ · Series A · Series A+ · Series B · Series B+ · Series C · Series C+ · Series D · Series E · Series F · Growth Equity
- Sectors
- Biotech · Healthcare · Digital Health · Medical Devices
- Regions
- Global · United States
Availability
- Currently deploying
- Yes
Portfolio and track record
Portfolio context
Notable portfolio companies include: Arrivo BioVentures LLC: A significant holding with Michael Ackermann serving as CCO. AEGEA Medical: Led a $17M financing round. Vektor Medical: Co-led a $16M Series A round. EirSystems: Seed round investment. Vesalio: Investment led by Solas BioVentures. CardioNXT: Another portfolio company.
Common questions
What to know about Solas BioVentures
Upseed classifies Solas BioVentures under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
April 9, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.